2nd Quarter - Termination

VAN SCOYOC ASSOCIATES for ALTIMMUNE, INC.

Firm
Client
Income
$50,000
Expenses
—
Terminated
Jun 9, 2021

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

COVID-19 Vaccine and manufacturing related issues

LobbyistCovered position, as disclosed
RAY COLE —
CHAD SCHULKEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

COVID-19 Vaccine and manufacturing related issues

LobbyistCovered position, as disclosed
RAY COLE —
CHAD SCHULKEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

COVID-19 Vaccine development issues

LobbyistCovered position, as disclosed
RAY COLE —
CHAD SCHULKEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

COVID-19 Vaccine and manufacturing related issues

LobbyistCovered position, as disclosed
RAY COLE —
CHAD SCHULKEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.